ArticleFrontiers in oncology2023

The efficacy and safety of lenvatinib plus transarterial chemoembolization in combination with PD-1 antibody in treatment of unresectable recurrent hepatocellular carcinoma: a case series report.

Chunyang Mu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.